HomeCompareKDEVF vs EQR

KDEVF vs EQR: Dividend Comparison 2026

KDEVF yields 776.40% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KDEVF wins by $2155130.31M in total portfolio value
10 years
KDEVF
KDEVF
● Live price
776.40%
Share price
$0.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2155130.35M
Annual income
$1,719,469,837,693.08
Full KDEVF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — KDEVF vs EQR

📍 KDEVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDEVFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDEVF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDEVF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDEVF
Annual income on $10K today (after 15% tax)
$65,993.79/yr
After 10yr DRIP, annual income (after tax)
$1,461,549,362,039.12/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, KDEVF beats the other by $1,461,549,357,384.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDEVF + EQR for your $10,000?

KDEVF: 50%EQR: 50%
100% EQR50/50100% KDEVF
Portfolio after 10yr
$1077565.20M
Annual income
$859,734,921,584.34/yr
Blended yield
79.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

KDEVF
No analyst data
Altman Z
34.5
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDEVF buys
0
EQR buys
0
No recent congressional trades found for KDEVF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDEVFEQR
Forward yield776.40%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$2155130.35M$47.8K
Annual income after 10y$1,719,469,837,693.08$5,475.61
Total dividends collected$2120503.05M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KDEVF vs EQR ($10,000, DRIP)

YearKDEVF PortfolioKDEVF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$88,340$77,639.75$11,380$679.82+$77.0KKDEVF
2$735,521$640,997.79$13,014$837.25+$722.5KKDEVF
3$5,774,840$4,987,832.38$14,961$1,036.20+$5.76MKDEVF
4$42,778,379$36,599,299.65$17,297$1,289.22+$42.76MKDEVF
5$299,153,457$253,380,592.07$20,121$1,613.15+$299.13MKDEVF
6$1,976,090,166$1,655,995,967.05$23,561$2,030.84+$1976.07MKDEVF
7$12,337,648,744$10,223,232,266.09$27,783$2,573.54+$12337.62MKDEVF
8$72,853,982,687$59,652,698,531.09$33,013$3,284.39+$72853.95MKDEVF
9$407,159,361,070$329,205,599,594.50$39,547$4,223.51+$407159.32MKDEVF
10$2,155,130,354,038$1,719,469,837,693.08$47,791$5,475.61+$2155130.31MKDEVF

KDEVF vs EQR: Complete Analysis 2026

KDEVFStock

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.

Full KDEVF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this KDEVF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDEVF vs SCHDKDEVF vs JEPIKDEVF vs OKDEVF vs KOKDEVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.